The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

NCT01148004 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

HIV
Fenofibrate
Protease Inhibitors
Hypertriglyceridemia
Glucuronosyltransferase

Interventions

DRUG: Fenofibrate
DRUG: Ritonavir
DRUG: Lopinavir/Ritonavir

Sponsor

National Institutes of Health Clinical Center (CC)